1 week ago
It's conducting nan study pinch glucosuria experts from Massachusetts General Hospital.
Samsung
Samsung has teamed up pinch the Massachusetts General Hospital (MGH) Diabetes Research Center to investigate really wearables tin thief group connected GLP-1 negociate musculus loss. They're specifically using Galaxy Watch 8, which nan institution released past year, for their study. Samsung says nan study will attraction connected investigating nan "feasibility of managing musculus nonaccomplishment for GLP-1 patients by utilizing biometric information including assemblage composition, activity levels and bosom complaint provided by Galaxy Watch and Samsung Health."
In its announcement, nan institution has referenced a KFF poll that says nearly 1 successful 5 adults successful nan US has taken a GLP-1 supplier astatine immoderate constituent to negociate Type 2 glucosuria and to suffer weight. With that galore group utilizing nan medication, it's nary astonishment that companies for illustration Samsung would want to incorporated features that would service them into their products.
At this point, scientists are still figuring retired nan semipermanent effects of utilizing GLP-1. Mayo Clinic's David N. Brennan, M.D. said 1 of doctors' emerging concerns is nan nonaccomplishment of musculus mass. Over 30 percent of weight nonaccomplishment connected nan medicine tin beryllium from muscle, he wrote. And while it's not that different from nan musculus nonaccomplishment 1 experiences pinch different weight-loss methods, scientists are worried that patients aren't ever regaining that musculus erstwhile they regain weight aft stopping treatment.
Researchers from nan University of Virginia conducted a study into musculus nonaccomplishment from GLP-1 narcotics and determined that it could undermine semipermanent health. "This is simply a superior concern. Muscle, particularly axial muscle, is basal for posture, beingness usability and wide well-being," they wrote. They explained that losing thin assemblage wide increases nan consequence of cardiovascular diseases, which could lead to diminished value of life.
Samsung's study, which will beryllium led by Dr. Melissa Putman from nan MGH Diabetes Research Center, will disagreement 100 adults conscionable starting GLP-1 curen into 2 groups. One group will usage Galaxy Watch 8 to show their assemblage creation pinch its Bioelectrical Impedance Analysis (BIA), arsenic good arsenic to way their beingness activity and to get personalized workout guides to forestall nan nonaccomplishment of muscles. The different group will beryllium fixed nan modular guidance astir group taking GLP-1 get. Researchers will past use clinical-grade DXA scans to way nan changes successful nan participants' assemblage composition. By comparing results betwixt nan 2 group, they tin fig retired if wearables for illustration nan Galaxy Watch 8 tin efficaciously support group connected nan medication.
"Many GLP-1 patients struggle pinch musculus wide loss, a communal broadside effect that tin origin an accrued consequence of cardiovascular illness and a driblet successful basal metabolic rate, which tin lead to early weight regain," said Dr. Putman. "We're willing successful exploring really continuous information from a wearable instrumentality tin supply invaluable insights into a patient's activity levels, bosom complaint and assemblage composition, giving clinicians a much holistic position of curen effect and allowing for much timely, data-driven adjustments to their attraction plan."
Samsung regularly collaborates pinch acquisition institutions to find really its wearables tin beryllium utilized to show and foretell wellness problems. It teamed up pinch Stanford University past twelvemonth to amended its slumber apnea feature. More recently, it said it figured retired how to foretell fainting with "high accuracy" aft moving pinch nan Chung-Ang University Gwangmyeong Hospital successful Korea.
